July 09, 2014 10:28 PM ET

Pharmaceuticals

Company Overview of Xel Pharmaceuticals, Inc.

Company Overview

Xel Pharmaceuticals, Inc. develops proprietary drug delivery and extraction technologies and products. Its products include XEL 001HP, a Huperzine A transdermal patch for the treatment of Alzheimer's disease; and XEL 002BP, a Bulleyaconitine transdermal patch for pain management. Xel Pharmaceuticals, Inc. was formerly known as Xel Herbaceuticals, Inc. The company was founded in 1999 and is based in Draper, Utah.

12382 Gateway Park Place

Suite B800

Draper, UT 84020

United States

Founded in 1999

Phone:

801-748-3550

Fax:

801-748-3555

Key Executives for Xel Pharmaceuticals, Inc.

Co-Founder
Co-Founder and Chairman of the Board
Age: 63
Co-Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
VeroScience, LLC United States
VR1 Corp United States
Velocity Pharmaceutical Development, LLC United States
Lakewood-Amedex Inc. United States
Good To Grow LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Xel Pharmaceuticals, Inc., please visit www.xelpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.